Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2025 is -96.41% vs 0.00% in Mar 2024
Consolidate Net Profit
YoY Growth in quarter ended Mar 2025 is 811.54% vs 93.95% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2025 is 47.71% vs 49.67% in Mar 2024
Interest
YoY Growth in quarter ended Mar 2025 is -55.88% vs 3.03% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024
Compare Quarterly Results Of BioLineRx Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2025 is -97.93% vs 136.41% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -96.41% vs 0.00% in Mar 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2025 is 256.78% vs 45.37% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 811.54% vs 93.95% in Mar 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2025 is -40.35% vs 66.27% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 47.71% vs 49.67% in Mar 2024
Quarterly - Interest
QoQ Growth in quarter ended Mar 2025 is -90.96% vs 176.67% in Dec 2024
YoY Growth in quarter ended Mar 2025 is -55.88% vs 3.03% in Mar 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024
YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024






